当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes
Blood ( IF 21.0 ) Pub Date : 2018-01-11 , DOI: 10.1182/blood-2017-10-812495
Anuhya Kommalapati 1 , Sri Harsha Tella 1 , Martin Durkin 2 , Ronald S. Go 3 , Gaurav Goyal 3
Affiliation  

TO THE EDITOR: Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system that is diagnosed using immunohistochemistry markers, such as CD68, lysozyme, CD4, and CD163, on the tissue biopsies.[1][1] HS can occur in

中文翻译:

组织细胞肉瘤:基于人群的发病率、人口差异和长期结果分析

致编辑:组织细胞肉瘤 (HS) 是一种罕见的造血肿瘤,源自单核细胞/巨噬细胞系统的非朗格汉斯组织细胞,可通过组织活检中的免疫组织化学标志物(如 CD68、溶菌酶、CD4 和 CD163)进行诊断。 [1][1] HS 可能发生在
更新日期:2018-01-11
down
wechat
bug